Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
Jun LuYu XuYuan WuXiao-Yan HuangJian-Wei XieJia-Bin WangJian-Xian LinPing LiChao-Hui ZhengAi-Min HuangChang-Ming HuangPublished in: BMC cancer (2019)
The current controlled trial was registered at ClinicalTrials.gov (ID: NCT02327481 ) on December 30, 2014.